secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001193125-26-149590
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera converts 76.5K Series B preferred into 76.5M common shares; warrants exercised
--------------------------------------------------------------------------------

- Converted 76,479.175 Series B Preferred shares into 76,479,164 common shares on April 7, 2026.
- After conversion, 42,839.11 Series B Preferred shares remain outstanding.
- Ikarian Capital affiliates exercised pre-funded warrants for 8,488,229 common shares at $0.001/share on April 8, 2026.
- Remaining pre-funded warrants to purchase 14,552,811 common shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526149590/0001193125-26-149590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526149590/d136871d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-149590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer